2018, Number 4
Next >>
Rev Hematol Mex 2018; 19 (4)
A purpose of prognostic factors in the lymphoblastic leukemia of the child
González-Llano Ó
Language: Spanish
References: 13
Page: 161-163
PDF size: 231.99 Kb.
Text Extraction
No abstract.
REFERENCES
Pinkel D, et al. Nine year’s experience with “Total Therapy” of childhood acute lymphocyte leukemia. Pediatrics 1972;50:246-251.
Krawczyk J, et al. In search of Pinkel’s children: unravelling the biological heterogeneity of childhood acute lymphoblastic leukaemia by genotype and treatment molecular response. J Med Sci 2013;182:377-382.
Bhatia S, et al. 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children’s Oncology Group study. Blood 2014;124:2345-53.
Orgel E, et al. Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia. Blood 2014;124:3932-8.
den Hoed MA, et al. The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia. Haematologica 2015;100:62-9.
Sala A, et al. Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: a perspective from Central America. Eur J Cancer 2012;48:243-252.
Rodríguez L, et al. Delivery of pediatric cancer care in Mexico: A national survey. J Global Oncology 2018;4:1-12.
Grupta S, et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer 2011;117:4788-95.
Magrath I, el al. Pediatric cancer in low-income and middleincome countries. Lancet Oncol 2013;14:e104-16.
Caniza MA, et al. Infectious complications in children with acute lymphoblastic leukemia treated in low-middleincome countries. Expert Rev Hematol 2015;8:627-45.
Shalkow J, et al. Comportamiento epidemiológico del cáncer en menores de 18 años. México 2008-2014. Boletín CENSIA.
Alemani C, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018;391:1023-1075.
Castellanos EM. Experiencia de la AHOPCA en el tratamiento del Linfoma de Hodgkin. XXIV Congreso de la Agrupación Mexicana de Onco-Hematología Pediátrica. Toluca 2018.
Full text